| Is it worth while changing clinically stable schizophrenic out-patients with mild to moderate residual symptoms and/or side effects from conventional to atypical antipsychotics? A prospective, randomised study with olanzapine. | |
| | |
MedLine Citation:
|
PMID: 15589715 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Fifty clinically stable, schizophrenic outpatients, suffering from residual schizophrenic symptoms and/or neurological side effects, were randomised to either continue their conventional neuroleptic(s) or change it to olanzapine. After 12 weeks patients on olanzapine exhibited significant improvement in neurological side effects and psychotic symptomatology as compared to patients on conventional antipsychotics. |
| | |
Authors:
|
Björn Appelberg; Katinka Tuisku; Grigori Joffe |
Related Documents
:
|
6605965 - Clinical differences between schizophrenic patients with and without large cerebral ven... 20838215 - Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlle... 1981295 - A statistical trial of subclassification for tardive dyskinesia. 8832775 - A comparison of instrument sensitivity to negative symptom change. 12420865 - Field evaluation of the effect of in-feed doxycycline for the control of ileitis in wea... 20731275 - Evaluation of the efficacy of pharmacotherapy and psychotherapy in treatment of combat-... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: European psychiatry : the journal of the Association of European Psychiatrists Volume: 19 ISSN: 0924-9338 ISO Abbreviation: Eur. Psychiatry Publication Date: 2004 Dec |
Date Detail:
|
Created Date: 2004-12-13 Completed Date: 2005-05-05 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 9111820 Medline TA: Eur Psychiatry Country: France |
Other Details:
|
Languages: eng Pagination: 516-8 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry, Helsinki University Central Hospital, POB 590, 00029 Hus, Finland. bjorn.appelberg@helsinki.fi |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Ambulatory Care* Antipsychotic Agents / adverse effects* Benzodiazepines / therapeutic use* Chlorpromazine / therapeutic use Female Humans Male Middle Aged Prospective Studies Schizophrenia / diagnosis, therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Antipsychotic Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 50-53-3/Chlorpromazine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The fractal box dimension on human eyeball movement--objective, biological marker of schizophrenia?
Next Document: The NMR response of boroxol rings: a density functional theory study.